ITOS News and Press, iTeos Therapeutics Inc. From 08/02/22

WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 02, 2022 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced that Mich...

Today, we put clinical stage oncology concern iTeos Therapeutics, Inc. in the spotlight for the first time. The company has two main oncology assets in development and a big partnership with GlaxoSmithKline. An investment analysis follows in the paragraphs below. Dan...

Our Marketplace Contributor Roundtable Series finishes with a wide range of coverage. Seven of our top contributors discuss what they're looking for this earnings season in value, commodities, and macro. As always, SA Marketplace articles are never paywalled. ~ By Tim ...

Biotechnology/Pharmaceuticals and Healthcare providers are undervalued relative to historical averages. Healthcare equipment is the most overvalued subsector. Fast facts on IYH. This monthly article series shows a dashboard with aggregate industry metrics in healthcare. ...

These July sample selections are the current top positive/negative forensic stocks out of 8,000 stocks based on combined scores from four top forensic algorithms. The January Positive Forensic portfolio is beating the S&P 500 by +1.59% YTD. The Negative portfolio is beating by +13...

The pharmaceutical/biotechnology subsector has the best value and quality scores. Healthcare equipment is the most overvalued industry. IHF: a concentrated ETF in healthcare providers. 10 stocks cheaper than their peers in June. For further details see: IHF: Healthca...

The 2022 American Society of Clinical Oncology Annual Meeting that begins June 3 is perhaps is the most eagerly anticipated medical meeting of the year. Thousands of abstracts and studies will be presented from pharma and biotech companies large and small. Some of the results are ea...

Pharmaceuticals and biotechnology are cheap relative to 11-year valuation averages. Life science tools and healthcare equipment are overvalued. IXJ: a global alternative to XLV. 10 stocks cheaper than their peers in May. For further details see: IXJ: Healthcare Dashb...

iTeos Therapeutics press release (NASDAQ:ITOS): Q1 GAAP EPS of $1.82 beats by $1.02. The company’s cash and cash equivalent position was $824.0 million as of March 31, 2022, as compared to $321.4 million as of March 31, 2021. Cash balance provides the company runway into 2026. For fu...

Enrolling patients with multiple myeloma in clinical trial of anti-TIGIT monoclonal antibody, EOS-448/GSK4428859A in monotherapy and in combination with BMS’s novel CELMoD agent, iberdomide. Enrolling patients in the biomarker cohort in an ongoing clinical trial of in...